0001104659-23-080926.txt : 20230713
0001104659-23-080926.hdr.sgml : 20230713
20230713212502
ACCESSION NUMBER: 0001104659-23-080926
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230713
FILED AS OF DATE: 20230713
DATE AS OF CHANGE: 20230713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KPCB PANDEMIC & BIO DEFENSE FUND LLC
CENTRAL INDEX KEY: 0001356809
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41742
FILM NUMBER: 231087868
BUSINESS ADDRESS:
STREET 1: 2750 SAND HILL RD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-233-2750
MAIL ADDRESS:
STREET 1: 2750 SAND HILL RD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KPCB PBD Associates, LLC
CENTRAL INDEX KEY: 0001497523
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41742
FILM NUMBER: 231087869
BUSINESS ADDRESS:
STREET 1: C/O KLEINER PERKINS CAUFIELD & BYERS
STREET 2: 2750 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-233-2750
MAIL ADDRESS:
STREET 1: C/O KLEINER PERKINS CAUFIELD & BYERS
STREET 2: 2750 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sagimet Biosciences Inc.
CENTRAL INDEX KEY: 0001400118
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205991472
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 155 BOVET RD., SUITE 303
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: (650) 561-8600
MAIL ADDRESS:
STREET 1: 155 BOVET RD., SUITE 303
CITY: SAN MATEO
STATE: CA
ZIP: 94402
FORMER COMPANY:
FORMER CONFORMED NAME: 3-V Biosciences, Inc.
DATE OF NAME CHANGE: 20070521
3
1
tm2321276-12_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2023-07-13
0
0001400118
Sagimet Biosciences Inc.
SGMT
0001497523
KPCB PBD Associates, LLC
C/O KLEINER PERKINS CAUFIELD & BYERS
2750 SAND HILL ROAD
MENLO PARK
CA
94025
0
0
1
0
0001356809
KPCB PANDEMIC & BIO DEFENSE FUND LLC
C/O KLEINER PERKINS CAUFIELD & BYERS
2750 SAND HILL ROAD
MENLO PARK
CA
94025
0
0
1
0
Common Stock
38763
I
See footnote
Series A Preferred Stock
Common Stock
6781
I
See footnote
Series B Preferred Stock
Common Stock
6208
I
See footnote
Series B-1 Preferred Stock
Common Stock
108163
I
See footnote
Series C Preferred Stock
Common Stock
108163
I
See footnote
Series D Preferred Stock
Common Stock
76796
I
See footnote
Series E Preferred Stock
Common Stock
1297549
I
See footnote
Series F Preferred Stock
Common Stock
257052
I
See footnote
Represents shares held directly by KPCB Pandemic and Bio Defense Fund, LLC ("KPCB PBD"). The managing member of KPCB PBD is KPCB PBD Associates, LLC ("KPCB PBD Associates"). All securities are held for convenience in the name of "KPCB Holdings, Inc., as nominee". KPCB PBD Associates disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of any of the reported shares for purposes of Section 16 or any other purpose.
Each share of Series A Preferred Stock, Series B Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock (collectively, the "Preferred Stock") is convertible into Common Stock on a 79.4784-to-one basis (on an adjusted basis, after giving effect to the reverse stock split of the Common Stock effected by the Issuer on July 7, 2023) at the option of the holder, and will convert automatically upon closing of the Issuer's initial public offering into the number of shares shown in column 3. The Preferred Stock has no expiration date.
KPCB PBD Associates, LLC, By: /s/ Susan Biglieri, CFO
2023-07-13
KPCB Pandemic and Bio Defense Fund, LLC, By: KPCB PBD Associates, LLC, its managing member, By: /s/ Susan Biglieri, CFO
2023-07-13